E. Nagyova

Targeted next-generation sequencing in Slovak cardiomyopathy patients.

F. Asselbergs, L. Kádasi, T. Szemeš, 2019, Bratislavske lekarske listy.

Transcriptional regulation profiling reveals disrupted lipid metabolism in failing hearts with a pathogenic phospholamban mutation

Johannes M. I. H. Gho, P. Doevendans, M. Mokry, 2020, bioRxiv.

Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

I. Efimov, H. Uh, M. Mokry, 2021, Clinical Epigenetics.